Advertisement

Drugmaker pauses drug rollout after facing criticism over price

By Associated Press  |  February 14, 2017

Marathon Pharmaceuticals will temporarily halt the rollout of a drug to treat genetic muscle deterioration after facing criticism over their plan to charge $89,000 a year for a drug that's widely available abroad for about $1,000 a year.

Editorial: 'Right to try' laws could impede medical progress

Editorial: 'Right to try' laws could impede medical progress

By Merrill Goozner  |  February 11, 2017

The Trump administration has thrown its weight behind giving patients the “right to try” experimental drugs outside clinical trials. While such laws purport to offer hope for the dying, they will actually slow medical progress.

Using electronic health records to manage warfarin drug

Using electronic health records to manage warfarin drug

By Elizabeth Whitman  |  February 11, 2017

Complications from warfarin can be serious. According to one study published in 2011, it is implicated in 33% of adverse drug events in patients 65 or older, and nearly all of those events are from unintentional overdoses.

Report: Drug price increases were tame in 2016

By Adam Rubenfire  |  February 06, 2017

Per-person prescription drug spending increased 3.8% for health plans covering employees and their families, a tame increase when compared to the year before, according to a new report from Express Scripts.

Innovations: ID Genomics takes the guesswork out of antibiotics

Innovations: ID Genomics takes the guesswork out of antibiotics

By Maria Castellucci  |  February 04, 2017

ID Genomics intends to allow physicians to quickly detect specific types of UTIs and the best antibiotics to treat them. “It is like we are creating a criminal dossier of bacterial strains,” says the startup's founder, Dr. Evgeni Sokurenko.

Advertisement